Nabriva Therapeutics plc
Nabriva Therapeutics plc, a biopharmaceutical company headquartered in Ireland, focuses on developing innovative therapies for serious infections. Founded in 2006, Nabriva has made significant strides in the antibiotic sector, particularly in the treatment of acute bacterial infections. The company is renowned for its unique portfolio of products, including its lead antibiotic, which addresses the growing challenge of antibiotic resistance. Nabriva's commitment to advancing antimicrobial therapies positions it as a key player in the global healthcare landscape. With a strong presence in both Europe and the United States, Nabriva Therapeutics continues to achieve notable milestones, reinforcing its reputation for excellence in the biopharmaceutical industry.
DitchCarbon Score
How does Nabriva Therapeutics plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nabriva Therapeutics plc's score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nabriva Therapeutics plc's reported carbon emissions
Nabriva Therapeutics plc, headquartered in Ireland (IE), currently does not have any publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives outlined in their climate commitments. Without specific emissions figures or reduction strategies, it is challenging to assess their current environmental impact or commitments to climate action. As the biopharmaceutical industry increasingly focuses on sustainability, Nabriva's future climate strategies may align with industry standards, but further information would be necessary to provide a comprehensive overview of their carbon footprint and climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nabriva Therapeutics plc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
